Ascletis Pharma Inc.
Ascletis Pharma Inc. (HKSE: 1672) is trading at HK$8.56, about ₹105 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 2.28% today. Indian residents can buy Ascletis Pharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$8.45
Today's high
HK$8.76
52 week low
HK$7.95
52 week high
HK$19.86
1672 opened at HK$8.76, closed previously at HK$8.76, and has traded between HK$7.95 and HK$19.86 over the past 52 weeks.
About
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.
Key statistics
Avg. volume
2.81M
Market cap
HK$8.97B
P/E Ratio
-12.40
Price-to-sales ratio
8097.82
Enterprise value
CN¥7.08B
Free cash flow yield
-4.95%
Debt-to-equity ratio
0.00
Return on equity
-28.15%
ROIC
-29.29%
Beta
0.39
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥2.03M
Earnings per share
-CN¥0.37
Free cash flow
-CN¥330.83M
Net profit margin
-62508.34%
Gross margin
-863.41%
EBITDA
-CN¥471.65M
Revenue growth
58.07%
Similar securities
This is not an investment recommendation
How to buy Ascletis Pharma from India
Indian residents can buy Ascletis Pharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Ascletis Pharma and place an order
Find Ascletis Pharma by name or by its ticker, 1672, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Ascletis Pharma trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Ascletis Pharma position in HKD and INR. Ascletis Pharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Ascletis Pharma from India
Trading and taxes when buying Ascletis Pharma from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneAscletis Pharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Ascletis Pharma stock?
Yes. Ascletis Pharma (1672) has been listed on the Hong Kong Stock Exchange since 2018, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Ascletis Pharma share cost in rupees?
One Ascletis Pharma share is HK$8.56 — about ₹105 at an HKD/INR rate of 12.25 on 24 Sep 2026. Both the Ascletis Pharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Ascletis Pharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Ascletis Pharma?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Ascletis Pharma shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Ascletis Pharma price. Paasa issues a capital-gains statement for your return.
Does Ascletis Pharma pay a dividend?
No. Ascletis Pharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Ascletis Pharma from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Ascletis Pharma shares held from India?
Hong Kong has no estate duty.
Do I have to declare Ascletis Pharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Ascletis Pharma holding, its cost and its closing value.
How do I sell Ascletis Pharma and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.